Postdoctoral fellow, Université de Montréal

I completed my undergraduate studies at the University of Melbourne, before moving to the University of New South Wales to work on my PhD. After several years studying the role of the orexin system in appetitive motivation and addiction, I commenced a postdoc at Concordia University in Montreal, where I worked on the role of glutamate in processing appetitive cues. I am currently studying cocaine addiction at the Université de Montréal. I independently study author choice and academic publishing behaviour and founded a non-profit academic community publisher to provide free open access publishing for neuroscientists.

Experience

  • 2019–present
    Postdoctoral fellow, Université de Montréal
  • 2017–2019
    Postdoctoral fellow, Concordia University

Education

  • 2017 
    University of New South Wales, Doctor of Philosophy (Psychology)
  • 2012 
    University of Melbourne, Bachelor of Science (Honours)
  • 2011 
    University of Melbourne, Bachelor of Arts

Publications

  • 2019
    Journal of Psychopharmacology, The medial prefrontal cortex is required for responding to alcohol-predictive cues but only in the absence of alcohol delivery
  • 2019
    Neuroscience of Nicotine: Mechanisms and Treatment, The orexin system and nicotine addiction: Preclinical insights
  • 2019
    LIBER Quarterly, Article processing charge hyperinflation and price insensitivity: An open access sequel to the serials crisis
  • 2019
    Student Success, Transitions and choices: Graduate student mentoring for psychology honours students
  • 2019
    Neuropsychopharmacology, Context and topography determine the role of basolateral amygdala metabotropic glutamate receptor 5 in appetitive Pavlovian responding
  • 2018
    Laboratory Animals, Local anaesthetic refinement of pentobarbital euthanasia reduces abdominal writhing without affecting immunohistochemical endpoints in rats
  • 2018
    Progress in Neuropsychopharmacology & Biological Psychiatry, Palatable food self-administration and reinstatement are not affected by dual orexin receptor antagonism
  • 2018
    LIBER Quarterly, A very long embargo: Journal choice reveals active non-compliance with funder open access policies by Australian and Canadian neuroscientists
  • 2018
    Animals, Justifiability and animal research in health: Can democratisation help resolve difficulties?
  • 2017
    Genes, Brain & Behavior, How contexts promote and prevent relapse to drug seeking
  • 2017
    PLoS ONE, The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking
  • 2016
    Addiction Biology, Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats
  • 2015
    The Journal of Neuroscience, Multiple properties of drug-paired cues may precipitate reinstatement
  • 2014
    CNS Drugs, Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?
  • 2013
    The International Journal of Neuropsychopharmacology, Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats